On April 24, 2025, Medtronic announced a strategic U.S. distribution agreement with Dragonfly™ Endoscopy, Inc. for its advanced Dragonfly™ pancreaticobiliary system. The system enhances endoscopic procedures in the bile and pancreatic ducts by offering superior visualization, a 42% larger working channel, and the ability to obtain larger biopsy samples and use more durable lithotripsy probes.
Previous ArticleFor colon cancer that no longer responds to treatment, a new drug combination offers hope (EurekaAlert!)
Next Article The Growing Impact of Biosimilars in IBD Care (AJMC)
Keep Reading
Add A Comment